Cultural advice

The Australian National University acknowledges, celebrates and pays our respects to the Ngunnawal and Ngambri people of the Canberra region and to all First Nations Australians on whose traditional lands we meet and work, and whose cultures are among the oldest continuing cultures in human history.

Aboriginal and Torres Strait Islander peoples are advised that ANU Library collections may include images, names, voices, and other representations of deceased persons.

Material in the collection may contain terms, language or views that reflect the period in which the item was created and may be considered inappropriate today.

TGF beta 1 enhances MAD1 expression and stimulates promoter-bound Pol II phosphorylation: basic functions of C/EBP, SP and SMAD3 transcription factors

dc.contributor.authorHein, Nadine
dc.contributor.authorJiang, Kan
dc.contributor.authorCornelissen, Christian
dc.contributor.authorLüscher, Bernhard
dc.date.accessioned2018-11-29T22:55:06Z
dc.date.available2018-11-29T22:55:06Z
dc.date.issued2011
dc.date.updated2018-11-29T08:04:31Z
dc.description.abstractBackground: The MAD1 protein, a member of the MYC/MAX/MAD network of transcriptional regulators, controls cell proliferation, differentiation and apoptosis. MAD1 functions as a transcriptional repressor, one direct target gene being the tumor suppressor PTEN. Repression of this gene is critical to mediate the anti-apoptotic function of MAD1. Under certain conditions it also antagonizes the functions of the oncoprotein MYC. Previous studies have demonstrated that MAD1 expression is controlled by different cytokines and growth factors. Moreover we have recently demonstrated that the MAD1 promoter is controlled by the cytokine granulocyte colony-stimulating factor (G-CSF) through the activation of STAT3, MAP kinases and C/EBP transcription factors.Results: We observed that in addition to G-CSF, the cytokine transforming growth factor β (TGFβ1) rapidly induced the expression of MAD1 mRNA and protein in promyelocytic tumor cells. Moreover we found that C/EBP and SP transcription factors cooperated in regulating the expression of MAD1. This cooperativity was dependent on the respective binding sites in the proximal promoter, with the CCAAT boxes being bound by C/EBPα/β heterodimers. Both C/EBP and SP transcription factors bound constitutively to DNA without obvious changes in response to TGFβ1. In addition SMAD3 stimulated the MAD1 reporter, cooperated with C/EBPα and was bound to the core promoter region. Thus SMAD3 appears to be a potential link between TGFβ1 signaling and C/EBP regulated promoter activity. Moreover TGFβ1 stimulated the phosphorylation of polymerase II at serine 2 and its progression into the gene body, consistent with enhanced processivity.Conclusions: Our findings suggest that C/EBP and SP factors provide a platform of transcription factors near the core promoter of the MAD1 gene that participate in mediating signal transduction events emanating from different cytokine receptors. SMAD3, a target of TGFβ1 signaling, appears to be functionally relevant. We suggest that a key event induced by TGFβ1 at the MAD1 promoter is the recruitment or activation of cofactors, possibly in complex with C/EBP, SP, and SMAD3 transcriptional regulators, that control polymerase activity.
dc.format.mimetypeapplication/pdfen_AU
dc.identifier.issn1471-2199
dc.identifier.urihttp://hdl.handle.net/1885/153045
dc.publisherBioMed Central
dc.sourceBMC Molecular Biology
dc.subjectKeywords: CCAAT enhancer binding protein; CCAAT enhancer binding protein alpha; CCAAT enhancer binding protein beta; DNA; granulocyte colony stimulating factor; heterodimer; messenger RNA; mitogen activated protein kinase; nucleotidyltransferase; polymerase II; pro
dc.titleTGF beta 1 enhances MAD1 expression and stimulates promoter-bound Pol II phosphorylation: basic functions of C/EBP, SP and SMAD3 transcription factors
dc.typeJournal article
dcterms.accessRightsOpen Accessen_AU
local.bibliographicCitation.issue9
local.bibliographicCitation.lastpage2199
local.bibliographicCitation.startpage1471
local.contributor.affiliationHein, Nadine, College of Health and Medicine, ANU
local.contributor.affiliationJiang, Kan, Institute of Biochemistry and Molecular Biology, Medical School, RWTH Aachen University
local.contributor.affiliationCornelissen, Christian, Institute of Biochemistry and Molecular Biology, Medical School, RWTH Aachen University
local.contributor.affiliationLüscher, Bernhard, Institute of Biochemistry and Molecular Biology, Medical School, RWTH Aachen University
local.contributor.authoruidHein, Nadine, u1001977
local.description.notesImported from ARIES
local.identifier.absfor110202 - Haematology
local.identifier.absfor111201 - Cancer Cell Biology
local.identifier.absfor111204 - Cancer Therapy (excl. Chemotherapy and Radiation Therapy)
local.identifier.ariespublicationa383154xPUB1412
local.identifier.citationvolume12
local.identifier.doi10.1186/1471-2199-12-9
local.identifier.scopusID2-s2.0-79951857017
local.identifier.thomsonID000288329200001
local.type.statusPublished Version

Downloads

Original bundle

Now showing 1 - 1 of 1
Loading...
Thumbnail Image
Name:
01_Hein_TGF_beta_1_enhances_MAD1_2011.pdf
Size:
1.01 MB
Format:
Adobe Portable Document Format